Market Cap 245.70M
Revenue (ttm) 53.43M
Net Income (ttm) -52.49M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -98.24%
Debt to Equity Ratio 0.00
Volume 12,935,700
Avg Vol 4,636,622
Day's Range N/A - N/A
Shares Out 294.61M
Stochastic %K 69%
Beta 0.67
Analysts Strong Sell
Price Target $10.00

Company Profile

Invivyd, Inc., together with its subsidiaries, engages in the research, development, commercialization, and sale of antibody therapies for the prevention and treatment of viral infectious diseases in the United States. The company offers Pemivibart, a half-life extended investigational monoclonal antibody for the pre-exposure prophylaxis prevention of COVID-19 in adults and adolescents through injection under the PEMGARDA brand. It also develops VYD2311, a monoclonal antibody, which is in Phase...

Industry: Biotechnology
Sector: Healthcare
Phone: 781 819 0080
Address:
209 Church Street, New Haven, United States
student56
student56 Jul. 8 at 4:01 PM
$IVVD buyimg more
0 · Reply
student56
student56 Jul. 8 at 2:00 PM
$IVVD move it up
0 · Reply
Zackpedia
Zackpedia Jul. 8 at 12:08 PM
$IVVD Down to .86 support, you could’ve sold when I alerted and bought back.
1 · Reply
SupremeTrader93
SupremeTrader93 Jul. 7 at 8:00 PM
$TOVX .23 hold is key.. can this go ah 👀 $SKIN $BATL $IVVD
0 · Reply
inThaJungle
inThaJungle Jul. 7 at 5:29 PM
$IVVD cool naow dew 1.33
0 · Reply
alexx013
alexx013 Jul. 7 at 4:59 PM
$IVVD will kiss dollar
0 · Reply
Zackpedia
Zackpedia Jul. 7 at 4:38 PM
$IVVD Selling time at .98
1 · Reply
student56
student56 Jul. 7 at 4:19 PM
$IVVD go up. Give me 7$
1 · Reply
gb2017384
gb2017384 Jul. 7 at 4:12 PM
$IVVD THIS IS THE 3RD QUARTER WE ALL BEEN SO PATIENTLY WAITING FOR HOPEFULLY THE F.D.A WILL BE GRACEFUL ENOUGH TO LICENSE AND PATIENT THIER DRUG.
0 · Reply
Rollercoaster22
Rollercoaster22 Jul. 7 at 4:08 PM
$IVVD Nice. 😄
0 · Reply
Latest News on IVVD
Invivyd completes enrollment of LIBERTY clinical trial

2026-06-16T11:37:10.000Z - 22 days ago

Invivyd completes enrollment of LIBERTY clinical trial


Invivyd Transcript: H.C. Wainwright “HCW @ Home” Series

Jun 8, 2026, 10:00 AM EDT - 4 weeks ago

Invivyd Transcript: H.C. Wainwright “HCW @ Home” Series


Invivyd completes enrollment in DECLARATION trial

2026-06-01T11:06:59.000Z - 5 weeks ago

Invivyd completes enrollment in DECLARATION trial


Invivyd to Participate in Upcoming Investor Events

May 27, 2026, 7:01 AM EDT - 6 weeks ago

Invivyd to Participate in Upcoming Investor Events


Invivyd management to meet with BTIG

2026-05-19T19:50:10.000Z - 7 weeks ago

Invivyd management to meet with BTIG


Invivyd Transcript: AGM 2026

May 19, 2026, 8:30 AM EDT - 7 weeks ago

Invivyd Transcript: AGM 2026


Invivyd post earnings selloff overdone, says H.C. Wainwright

2026-05-14T19:05:42.000Z - 7 weeks ago

Invivyd post earnings selloff overdone, says H.C. Wainwright


Invivyd Earnings Call Transcript: Q1 2026

May 14, 2026, 8:30 AM EDT - 7 weeks ago

Invivyd Earnings Call Transcript: Q1 2026


Invivyd Earnings release: Q1 2026

May 14, 2026, 8:30 AM EDT - 7 weeks ago

Invivyd Earnings release: Q1 2026


Invivyd Slides: Q1 2026

May 14, 2026, 8:30 AM EDT - 7 weeks ago

Invivyd Slides: Q1 2026


Invivyd Quarterly report: Q1 2026

May 14, 2026, 8:30 AM EDT - 7 weeks ago

Invivyd Quarterly report: Q1 2026


Invivyd provides update on Phase 3 DECLARATION study of VYD2311

2026-04-09T13:34:05.000Z - 3 months ago

Invivyd provides update on Phase 3 DECLARATION study of VYD2311


Invivyd Transcript: Study update

Apr 9, 2026, 8:30 AM EDT - 3 months ago

Invivyd Transcript: Study update


Invivyd Press release: Study update

Apr 9, 2026, 8:30 AM EDT - 3 months ago

Invivyd Press release: Study update


Invivyd Slides: Study update

Apr 9, 2026, 8:30 AM EDT - 3 months ago

Invivyd Slides: Study update


Invivyd Proxy statement: Proxy filing

Apr 6, 2026, 8:00 AM EDT - 3 months ago

Invivyd Proxy statement: Proxy filing


Invivyd Proxy statement: Proxy filing

Apr 6, 2026, 8:00 AM EDT - 3 months ago

Invivyd Proxy statement: Proxy filing


Invivyd Earnings Call Transcript: Q4 2025

Mar 5, 2026, 8:30 AM EST - 4 months ago

Invivyd Earnings Call Transcript: Q4 2025


Invivyd Annual report: Q4 2025

Mar 5, 2026, 8:30 AM EST - 4 months ago

Invivyd Annual report: Q4 2025


Invivyd Earnings release: Q4 2025

Mar 5, 2026, 8:30 AM EST - 4 months ago

Invivyd Earnings release: Q4 2025


Invivyd Slides: Q4 2025

Mar 5, 2026, 8:30 AM EST - 4 months ago

Invivyd Slides: Q4 2025


Invivyd appoints Michael Mina as CMO

2026-03-05T12:20:37.000Z - 4 months ago

Invivyd appoints Michael Mina as CMO


Invivyd reports FY25 EPS (30c) vs. ($1.43) last year

2026-03-05T12:13:36.000Z - 4 months ago

Invivyd reports FY25 EPS (30c) vs. ($1.43) last year


Invivyd management to meet virtually with BTIG

2026-02-18T17:40:26.000Z - 4 months ago

Invivyd management to meet virtually with BTIG


Invivyd aligns with FDA on LIBERTY Phase 3 trial of VYD2311

2026-02-03T12:05:43.000Z - 5 months ago

Invivyd aligns with FDA on LIBERTY Phase 3 trial of VYD2311


Invivyd announces partnership with ski champion Lindsey Vonn

2026-01-22T12:16:53.000Z - 5 months ago

Invivyd announces partnership with ski champion Lindsey Vonn


Invivyd Slides: Corporate Presentation

Jan 8, 2026, 7:00 AM EST - 6 months ago

Invivyd Slides: Corporate Presentation


Invivyd Registration statement: Registration Filing

Dec 19, 2025, 7:00 AM EST - 7 months ago

Invivyd Registration statement: Registration Filing


Invivyd Announces Proposed Public Offering of Common Stock

Nov 17, 2025, 4:01 PM EST - 8 months ago

Invivyd Announces Proposed Public Offering of Common Stock


Invivyd Earnings Call Transcript: Q3 2025

Nov 6, 2025, 8:30 AM EST - 8 months ago

Invivyd Earnings Call Transcript: Q3 2025


Invivyd Quarterly report: Q3 2025

Nov 6, 2025, 8:30 AM EST - 8 months ago

Invivyd Quarterly report: Q3 2025


Invivyd Earnings release: Q3 2025

Nov 6, 2025, 8:30 AM EST - 8 months ago

Invivyd Earnings release: Q3 2025


Invivyd Slides: Q3 2025

Nov 6, 2025, 8:30 AM EST - 8 months ago

Invivyd Slides: Q3 2025


Invivyd Transcript: Study Update

Oct 30, 2025, 8:30 AM EDT - 8 months ago

Invivyd Transcript: Study Update


Invivyd Press release: Study Update

Oct 30, 2025, 8:30 AM EDT - 8 months ago

Invivyd Press release: Study Update


Invivyd Slides: Study Update

Oct 30, 2025, 8:30 AM EDT - 8 months ago

Invivyd Slides: Study Update


Invivyd Registration statement: Registration Filing

Oct 2, 2025, 8:00 AM EDT - 9 months ago

Invivyd Registration statement: Registration Filing


Invivyd Appoints Paul B. Bolno, M.D.

Sep 24, 2025, 4:01 PM EDT - 10 months ago

Invivyd Appoints Paul B. Bolno, M.D.


Invivyd Transcript: Cantor Global Healthcare Conference 2025

Sep 3, 2025, 2:10 PM EDT - 10 months ago

Invivyd Transcript: Cantor Global Healthcare Conference 2025


Invivyd to Participate in Upcoming Investor Conferences

Aug 27, 2025, 7:01 AM EDT - 11 months ago

Invivyd to Participate in Upcoming Investor Conferences


Invivyd Quarterly report: Q2 2025

Aug 14, 2025, 9:30 AM EDT - 11 months ago

Invivyd Quarterly report: Q2 2025


Invivyd Earnings release: Q2 2025

Aug 14, 2025, 9:30 AM EDT - 11 months ago

Invivyd Earnings release: Q2 2025


Invivyd Slides: Q2 2025

Aug 14, 2025, 9:30 AM EDT - 11 months ago

Invivyd Slides: Q2 2025


Invivyd Earnings Call Transcript: Q1 2025

May 15, 2025, 8:30 AM EDT - 1 year ago

Invivyd Earnings Call Transcript: Q1 2025


Invivyd Quarterly report: Q1 2025

May 15, 2025, 8:30 AM EDT - 1 year ago

Invivyd Quarterly report: Q1 2025


Invivyd Earnings release: Q1 2025

May 15, 2025, 8:30 AM EDT - 1 year ago

Invivyd Earnings release: Q1 2025


Invivyd Slides: Q1 2025

May 15, 2025, 8:30 AM EDT - 1 year ago

Invivyd Slides: Q1 2025


student56
student56 Jul. 8 at 4:01 PM
$IVVD buyimg more
0 · Reply
student56
student56 Jul. 8 at 2:00 PM
$IVVD move it up
0 · Reply
Zackpedia
Zackpedia Jul. 8 at 12:08 PM
$IVVD Down to .86 support, you could’ve sold when I alerted and bought back.
1 · Reply
SupremeTrader93
SupremeTrader93 Jul. 7 at 8:00 PM
$TOVX .23 hold is key.. can this go ah 👀 $SKIN $BATL $IVVD
0 · Reply
inThaJungle
inThaJungle Jul. 7 at 5:29 PM
$IVVD cool naow dew 1.33
0 · Reply
alexx013
alexx013 Jul. 7 at 4:59 PM
$IVVD will kiss dollar
0 · Reply
Zackpedia
Zackpedia Jul. 7 at 4:38 PM
$IVVD Selling time at .98
1 · Reply
student56
student56 Jul. 7 at 4:19 PM
$IVVD go up. Give me 7$
1 · Reply
gb2017384
gb2017384 Jul. 7 at 4:12 PM
$IVVD THIS IS THE 3RD QUARTER WE ALL BEEN SO PATIENTLY WAITING FOR HOPEFULLY THE F.D.A WILL BE GRACEFUL ENOUGH TO LICENSE AND PATIENT THIER DRUG.
0 · Reply
Rollercoaster22
Rollercoaster22 Jul. 7 at 4:08 PM
$IVVD Nice. 😄
0 · Reply
student56
student56 Jul. 7 at 3:42 PM
$IVVD entering
0 · Reply
Tamiru
Tamiru Jul. 7 at 2:40 PM
$IVVD 👀👀🚀
0 · Reply
billsmall
billsmall Jul. 6 at 9:22 PM
$IVVD Bottom line, nobody other than Insiders have any clue where this is headed. We can all assume but trust me they've conversations with the folks that make the final decisions and have a fairly clear path of what's going to happen one way or the other. We remain pawns in this game. Anybody have access as to latest buying or selling by large institutions? (Most likely data is to old to matter at this stage) What's everyone's thought at this stage? I'd like to hear good and bad. I know many just look at this as a COVID company and that may be it's nearest headwind but it's more than that and I just don't see all this angel investor money losing. They know the answer. Yes, I get COVID is dead but hell in my mind it's just a stronger case of the flu but they still sell millions of flu shots seasonally so that doesn't change. Again thoughts. (May be away for a couple of days) Is $10 out of the realm? I felt $7-$10 was a solid range and a bit higher on a buyout. Thoughts?
2 · Reply
mikesterz7
mikesterz7 Jul. 6 at 7:54 PM
$IVVD PEMGARDA’s emergency status will end on June 29, 2027, unless the company secures full FDA approval in the meantime.
1 · Reply
StocktwitsNews
StocktwitsNews Jul. 6 at 5:39 PM
IVVD Stock Drops As PEMGARDA Loses Emergency Authorization In 2027 — Invivyd Eyes Full FDA Approval $IVVD $ITOT $XBI https://stocktwits.com/news/equity/markets/ivvd-stock-drops-as-pemgarda-loses-emergency-authorization-in-2027/cZm1kO3R7ls
0 · Reply
gb2017384
gb2017384 Jul. 6 at 1:48 PM
$IVVD ,this is what happens when you try to steal a slice of action from the BIG BOYS PIE.
0 · Reply
focafoca99
focafoca99 Jul. 6 at 11:15 AM
$IVVD received a 12-month notice of termination for the PEMGARDA EUA and is discussing next steps with the FDA.
0 · Reply
UserID123456
UserID123456 Jul. 3 at 1:21 PM
$IVVD Why is this up? In a purely politically motivated move (shocking) our idiotic leader of the HHS has officially ended all COVID-19 emergency use authorization declarations. They’re giving a 12-month “advance notice” / grace period to manufacturers of drugs or biological products, and a 6-month period to manufacturers of medical devices, to shift to full approval/clearance. That means Pemgarda is cooked.
2 · Reply
gb2017384
gb2017384 Jun. 29 at 3:08 PM
$IVVD DO THESE INSIDE TRADERS KNOW SOMETHING WE SHOULD$.
3 · Reply
gb2017384
gb2017384 Jun. 29 at 1:45 PM
$IVVD ,I KNOW IF THIS IVVD STOCK TAKES A DUMP THERES GOING TO BE ALOT OF BANKRUPT INVESTORS ÷$$$$$$$$$$$$$$$$$$$$$$$$$$$$$.
0 · Reply
billsmall
billsmall Jun. 26 at 10:25 PM
$IVVD OK at 3:59 there was a 22 mil share trade. Was that you Nik bringing your SLS profits over LOL (Congratulations by the way) I have to admit I'm a bit perplexed how this is trading. Anyone?
2 · Reply
Rynr
Rynr Jun. 25 at 2:34 AM
$IVVD silence before the storm
1 · Reply